Beaten-Down Biotech Just Lost a Backer — Should You Care
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
If your budget isn't functioning, it's time for a change. Explore effective strategies to fix your budget and regain control of your finances.
13,885 articlesWhen a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Gaotu's Q1 2026 earnings reveal clues about growth, profitability, and execution in a competitive online education ma...
A long-running dividend payer with 70 straight years of increases is drawing buyers as its stock dips. The company pl...
A caller on a popular financial show maxed out cards flipping Pokemon. Dave Ramsey’s blunt take highlights the brutal...
Investors are watching Sinclair (SBGI) 2025 earnings closely as local ad markets and political cycles shape cash flow...
This guide shows investors how to interpret earnings transcripts for natural gas services. It covers key metrics, rea...
Take a practical tour of arcutis (arqt) 2026 earnings, from revenue mix and margins to pipeline progress and risk fac...
Senior executives are increasingly deferring about $100,000 of pay into non-qualified plans to extend tax-advantaged ...
Splitero has closed a $296 million home equity investment securitization, its second public HEI deal. The transaction...
With the MiCA deadline looming, a vast majority of EU crypto firms have not completed full licensing. Only a fraction...
Looking for fast-growing industrial mid-cap stocks with durable revenue streams? This guide breaks down two compellin...
A marquee collaboration turned cautionary tale. Explore how a failed merch deal unfolded, what it cost, and how to sh...